Marinus Pharmaceuticals: Q3 Earnings Snapshot

RADNOR, Pa. (AP) — RADNOR, Pa. (AP) — Marinus Pharmaceuticals Inc. (MRNS) on Tuesday reported a loss of $24.2 million in its third quarter.

The Radnor, Pennsylvania-based company said it had a loss of 42 cents per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.

The epilepsy drug developer posted revenue of $8.5 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up